A pilot naturalistic follow-up of extended sertraline treatment for severe premenstrual syndrome.
A pilot naturalistic follow-up of extended sertraline treatment for severe premenstrual syndrome.
复制标题
对严重经前综合症延长舍曲林治疗的试点自然随访。
DOI:
10.1097/01.jcp.0000126662.96529.6f
复制
发表时间:
2004
影响因子:
2.9
通讯作者:
Martin,PG
中科院分区:
文献类型:
--
作者:
Freeman,EllenW;Sondheimer,StevenJ;Rickels,Karl;Martin,PG
A 19-year-old African American man with a history of bipolar disorder presented 2.5 days after ingesting 12,000 mg quetiapine. He reported falling out of bed and lying unconscious for an unknown amount of time. He had no history of seizures and denied urinary or fecal incontinence or biting his tongue.Vital signs at the time of admission were blood pressure 129/80 mm Hg, pulse rate 120, respiratory rate 18, and temperature 98.08 F. On physical examination, the patient was confused, agitated, and unable to move his extremities due to pain. His concentration was decreased, and his short-term memory was impaired. Urine drug screen and blood alcohol level were negative. There was no evidence of ingestion of other substances, including the patient’s other 2 medications, acetaminophen and valproic acid. A computed tomography of the brain indicated no abnormal findings. Admission laboratory data 2.5 days after ingestion included creatine phosphokinase (CPK) 47,663, myoglobin 7267, blood urea nitrogen 68, creatinine 4.5, aspartate aminotransferase 779, alanine aminotransferase 274, and phosphorus 8.7. Toxicology included serum quetiapine 68 ng/mL, valproic acid 57 Ag/mL, and acetaminophen 2 Ag/mL. CPK and myoglobin peaked at 96,073 and 5573 (drawn 8 hours after admission).